Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00414401
Status:
COMPLETED
Last Update Posted:
2015-04-07
First Post:
2006-12-19
Brief Title:
Clinical Reminders in Test Reports to Improve Guideline Compliance
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Clinical Reminders in Test Reports to Improve Guideline Compliance
Status:
COMPLETED
Status Verified Date:
2006-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction their use in the community and the VA is suboptimal
Detailed Description:
Background
Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction their use in the community and the VA is suboptimal
Objectives
To determine if a reminder attached to the echocardiography report would increase the use of beta-blockers among patients with depressed left ventricular function
Methods
We are randomizing consecutive patients undergoing echocardiography at one of three VA echocardiography laboratories with reduced left ventricular ejection fraction 40 and no echocardiographic contraindication to beta-blockers eg aortic stenosis to a reminder for use of beta-blockers or to no reminder The reminder gives starting doses for two commonly used beta-blockers carvedilol and metoprolol Patients are excluded from the analysis if they leave the health care system or die within three months of randomization The primary outcome is a prescription for a beta-blocker between three and nine months following echocardiography
Status
The project is complete
Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction their use in the community and the VA is suboptimal
Objectives
To determine if a reminder attached to the echocardiography report would increase the use of beta-blockers among patients with depressed left ventricular function
Methods
We are randomizing consecutive patients undergoing echocardiography at one of three VA echocardiography laboratories with reduced left ventricular ejection fraction 40 and no echocardiographic contraindication to beta-blockers eg aortic stenosis to a reminder for use of beta-blockers or to no reminder The reminder gives starting doses for two commonly used beta-blockers carvedilol and metoprolol Patients are excluded from the analysis if they leave the health care system or die within three months of randomization The primary outcome is a prescription for a beta-blocker between three and nine months following echocardiography
Status
The project is complete
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None